British Journal of Haematology · 2001 · 38 citations · 31 references
PharmacyInfectious DiseasesPharmacotherapyAntimicrobial PharmacotherapyAntimicrobial ResistanceInfection PreventionAntibiotic ProphylaxisAntibiotic ResistanceAntimicrobial ProphylaxisAntimicrobial Resistance PreventionEmpiric Antimicrobial TherapyFebrile Neutropenia ManagementAntibiotic Resistance PreventionAntimicrobial Resistance MitigationInfection Prophylaxis In NeutropeniaNeutropenic Infection PreventionNeutropenic InfectionsProphylactic ChemotherapyProphylactic EfficacyTreatment Of Bacterial Resistance
Following a 2-year study, the combination of oral ciprofloxacin and colistin has been used continuously for 10 years without the emergence of resistance. During a 2-year period (1987-1989), we compared ciprofloxacin + colistin (CIP + COL) with neomycin + colistin (NEO + COL) in a randomized trial--combinations chosen because of the potential for prophylaxis of Gram-negative infection by ciprofloxacin, with colistin given to reduce the risk of emergence of resistance. Sixty-four patients with similar demographics in each arm were evaluable for efficacy analysis. Patients on CIP + COL had a significantly lower proportion of neutropenic days with fever (P < 0.001) and neutropenic days on intravenous antibiotics (P < 0.001) than patients on NEO + COL. A total of 54 (15 bacteriologically documented) pyrexial episodes occurred in patients on CIP + COL and 77 (41 bacteriologically documented) in patients on NEO + COL. Only two Gram-negative bacterial infections occurred in the CIP + COL arm compared with 16 in the NEO + COL arm. No Staphylococcus aureus infections occurred in the CIP + COL group compared with 10 in the other patients. Two CIP-resistant Gram-negative bacilli were isolated from patients on CIP + COL compared with 13 NEO-resistant Gram-negative bacilli from patients on NEO + COL. Following a subsequent decade of unchanged use of this prophylactic strategy in neutropenic patients, a 2-year follow-up study between 1 January 1998 and 31 December 1999 showed 66 significant infections during 700 [corrected] neutropenic episodes. Thirty-five of the 111 (31%) isolates were ciprofloxacin-resistant, involving 5% of the neutropenic episodes [corrected].
31
Origin of Infection in Acute Nonlymphocytic Leukemia
Stephen C. Schimpff · Annals of Internal Medicine · 1972 · 503 citations
Dietrich W. Beelen, Ahmet Elmaağaclı, Karl‐Dieter Müller et al. · Blood · 1999 · 268 citations